after this therapeutic method , the five-year survival rate in the stages t1 and t2 is 60 % for the myxosarcoma , 67 % for the angiosarcoma , 41 % for the fasciculated sarcoma , 40 % for the globocellular sarcoma , 30 % for the polymorphous sarcoma , 69 % for the fibrosarcoma , and 61 % for the leiomyosarcoma .
C1261473
sarcoma
C0016057
fibrosarcoma